Kwang-Soo Kim Related Content

Cell therapy holds promise as a new treatment for Parkinson’s disease, but in many trials to date, most transplanted dopamine cells have failed to survive, raising a fundamental obstacle. Recent advancements led by researchers at McLean Hospital and Massachusetts General Hospital could change this...

A team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) reported that reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) is technically feasible. PD is the second most common...

Investigators have identified two molecules naturally produced by the body that stimulate the production of dopamine, the molecule that is in short supply in the brains of patients with Parkinson’s disease. Stimulating dopamine production may help reverse the progression of the disease. The research...

Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of The...

In the United States alone, as many as one million people have Parkinson’s disease (PD), with approximately 60,000 cases being diagnosed each year, according to the Parkinson’s Disease Foundation. Kwang-Soo Kim, PhD , director of the Molecular Neurobiology Laboratory at McLean Hospital and professor...